Aviado · Research

Longevity Daily

Tuesday, September 29, 2026

Listen

Today's Brief

A major international report has declared Alzheimer's no longer untreatable, citing prevention strategies capable of blocking up to 45% of dementia cases — and it leads today's edition alongside a warning about a popular joint supplement that may accelerate cognitive decline. A landmark Nature paper shows that transplanted old hearts actually reverse their biological age inside younger hosts, offering some of the strongest evidence yet that aging trajectories are malleable. Irina Conboy publicly names the exact drug combination her Generation Lab has been testing in humans, including herself. And our Aviado team asks the question worth answering before you refill: are you taking the right vitamin D dose for your actual baseline level?

10 stories3 peer-reviewed1 Aviado original

Cognitive Health & Neuroprotection

Must ReadGlobe TV· 2026-09-29

Alzheimer's Is No Longer Untreatable: Major Report Signals a New Era in Dementia Care

A landmark report has concluded that Alzheimer's disease has crossed a genuine threshold — it can now be treated, and in many cases delayed or prevented. Researchers cite disease-modifying drugs alongside lifestyle and metabolic prevention strategies that could collectively block up to 45% of dementia cases from ever developing. For the first time, clinicians can offer patients something beyond symptom management, and the public health implications are enormous. If you have a family history of dementia or are actively optimizing your brain health, the case for early intervention has never been stronger.

Evidence CheckHealth and Me· 2026-09-28

GLP-1 Drugs Are Showing Real Promise for Brain Disease — Beyond Obesity

A double-blind, placebo-controlled trial (n=59) presented at the MDS Congress found that a GLP-1 receptor agonist produced significant improvements in Parkinson's motor symptoms over nine months (p=.001), and researchers are now tracking potential benefits for stroke recovery and direct neuroprotection. The review in NeurologyLive covers the growing evidence base repositioning these blockbuster drugs as serious candidates for neurological disease. If you are already taking a GLP-1 drug for metabolic health, the neurological upside may be a meaningful bonus — though dedicated brain-health trials are still underway.

Supplements & Compounds

New ResearchScienceAlert· 2026-09-29

Creatine Builds Strength and Protects Muscle — Even Without Going to the Gym

New research adds to growing evidence that creatine may preserve muscle mass and support brain function even in the absence of resistance training — a meaningful finding for older adults, people recovering from injury, or anyone going through an inactive stretch. Earlier data already suggested cognitive benefits independent of exercise; this latest work extends the case to lean mass preservation. The caveat: effects remain preliminary and exercise still appears to be the primary driver of creatine's well-documented benefits.

Aviado ResearchAviado Research· 2026-05-10

Vitamin D Only Works If You're Actually Deficient — Here's How to Dose It Right

Most people taking vitamin D are guessing their dose and may be getting nothing from it. Aviado Research's latest analysis explains why vitamin D's effectiveness depends almost entirely on your baseline 25(OH)D blood level: if you're already sufficient (above 30 ng/mL), supplementation is unlikely to produce any measurable benefit. The protocol is clear — test first, then calibrate: 2,000–4,000 IU daily if under 30 ng/mL, up to 5,000–6,000 IU for 8–12 weeks if under 20 ng/mL, with a retest before assuming it's working.

Read the full Aviado analysis →

Research & Papers

New ResearchNature· 2026-09-28

Old Hearts Age Backwards When Transplanted Into Younger Bodies, Nature Reports

A study published in Nature finds that old donor hearts transplanted into younger recipients do not simply keep aging at their original pace — they adjust their biological age downward to match the younger host's systemic environment. This is direct evidence that the rate of biological aging in an organ is not fixed by its cellular history alone, but is shaped by circulating signals and the body it lives in. The finding has significant implications for understanding how systemic interventions — from blood factor therapies to parabiosis research — might genuinely slow or reverse tissue aging.

New ResearchRapamycin Longevity News· 2026-09-28

Irina Conboy Reveals the Exact Drug Combination Her Lab Is Testing on Humans

Irina Conboy — one of the leading figures in blood-factor aging research — has publicly identified the precise drug combination that Generation Lab has been trialing in people, herself included. The formulation builds on years of research into the systemic factors that suppress youthful regeneration as we age, and represents one of the few longevity protocols currently being tested in humans rather than mice. This is a significant development for anyone tracking what serious longevity researchers are actually doing with their own biology.

Lifestyle & Nutrition

New ResearchAging Cell· 2026-09-28

A High-Carb Diet Reduced Biological Age, Weight, and Cholesterol in Under a Month

An Australian study published in Aging Cell tested four diets head-to-head and found that a specific high-carbohydrate eating pattern reduced biological age markers alongside weight and cholesterol — with measurable changes detectable in less than four weeks. The finding directly challenges the assumption that low-carb eating is synonymous with anti-aging diets. Small-study caveats apply, but if replicated, this research could meaningfully reshape longevity-focused dietary guidance.

New ResearchPNAS· 2026-09-28

Exercise Reverses Aging Through Mitochondrial Remodeling — and Your Cells Stay Plastic as You Age

New research published in PNAS identifies the cellular mechanism behind exercise's anti-aging effects: mitochondrial remodeling. Crucially, the study finds that this plasticity is retained even in older cells, meaning it is never too late to trigger meaningful mitochondrial adaptation through movement. The findings reinforce regular physical activity as one of the most evidence-backed and accessible longevity interventions available — with a specific biological explanation for why it works.

Industry & Policy

IndustryNeurology Advisor· 2026-09-28

FDA Panel Narrowly Backs Galleri Multi-Cancer Blood Test Despite Reliability Concerns

An FDA advisory panel has voted narrowly in favor of Galleri, a liquid biopsy test designed to detect more than 50 cancer types from a single blood draw — despite panel members voicing meaningful doubts about its real-world reliability. The split decision puts a spotlight on the tension between early-detection demand from health-optimizing consumers and the evidentiary bar regulators require before broadly endorsing screening tools. If you have been considering multi-cancer early detection testing, this ruling is worth following before committing.